Collaboration on One of the Leading Causes of Blindness Seeks to Find More Effective Treatments

Macular degeneration (AMD or ARMD)- is a medical condition which may result in blurred or no vision in the center of the visual field. Tunatura/Shutterstock

The Australian National University (ANU) has begun a collaboration with the Korean Biotech Company MDimune Inc. to develop new and more effective treatments for Age-related Macular Degeneration (AMD).

AMD is one of the leading causes of blindness globally and is expected to affect 288 million people in 2040.